Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Saved in:
| Title: | Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. |
|---|---|
| Authors: | Mithoefer MC; Medical University of South Carolina, Charleston, SC, USA., Feduccia AA; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA. alli@mapsbcorp.com., Jerome L; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA., Mithoefer A; Private Practice, Charleston, SC, USA., Wagner M; Medical University of South Carolina, Charleston, SC, USA., Walsh Z; University of British Columbia-Okanagan, Kelowna, BC, Canada., Hamilton S; Stanford School of Medicine, Stanford University, Stanford, CA, USA., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA., Emerson A; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA. |
| Source: | Psychopharmacology [Psychopharmacology (Berl)] 2024 Nov; Vol. 241 (11), pp. 2405. |
| Publication Type: | Retraction Notice |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39126501 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mithoefer+MC%22">Mithoefer MC</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Feduccia+AA%22">Feduccia AA</searchLink>; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA. alli@mapsbcorp.com.<br /><searchLink fieldCode="AU" term="%22Jerome+L%22">Jerome L</searchLink>; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mithoefer+A%22">Mithoefer A</searchLink>; Private Practice, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Wagner+M%22">Wagner M</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+Z%22">Walsh Z</searchLink>; University of British Columbia-Okanagan, Kelowna, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Hamilton+S%22">Hamilton S</searchLink>; Stanford School of Medicine, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yazar-Klosinski+B%22">Yazar-Klosinski B</searchLink>; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Emerson+A%22">Emerson A</searchLink>; MAPS Public Benefit Corporation, 1115 Mission St, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Doblin+R%22">Doblin R</searchLink>; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227608025%22">Psychopharmacology</searchLink> [Psychopharmacology (Berl)] 2024 Nov; Vol. 241 (11), pp. 2405. – Name: TypePub Label: Publication Type Group: TypPub Data: Retraction Notice – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7608025 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-2072 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200333158%22">00333158 </searchLink><i>NLM ISO Abbreviation: </i>Psychopharmacology (Berl) <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39126501 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00213-024-06666-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2405 Titles: – TitleFull: Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mithoefer MC – PersonEntity: Name: NameFull: Feduccia AA – PersonEntity: Name: NameFull: Jerome L – PersonEntity: Name: NameFull: Mithoefer A – PersonEntity: Name: NameFull: Wagner M – PersonEntity: Name: NameFull: Walsh Z – PersonEntity: Name: NameFull: Hamilton S – PersonEntity: Name: NameFull: Yazar-Klosinski B – PersonEntity: Name: NameFull: Emerson A – PersonEntity: Name: NameFull: Doblin R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1432-2072 Numbering: – Type: volume Value: 241 – Type: issue Value: 11 Titles: – TitleFull: Psychopharmacology Type: main |
| ResultId | 1 |
